Hosted on MSN1d
Barclays Downgrades Galapagos NV - Depositary Receipt () (GLPG)
Fintel reports that on January 23, 2025, Barclays downgraded their outlook for Galapagos NV - Depositary Receipt () (NasdaqGS:GLPG) from Equal-Weight to Underweight. Analyst Price Forecast Suggests 48 ...
Galapagos downgraded to Underweight from Equal Weight at Barclays
Barclays downgraded Galapagos (GLPG) to Underweight from Equal Weight with a price target of EUR 22, down from EUR 30. With Galapagos’ ongoing ...
The Pharma Letter3d
Catalent to support Galapagos’ decentralized cell therapy approach
Specifically, Catalent's commercial cell therapy manufacturing facility in Princeton, New Jersey, will support manufacturing ...